Paper · 41565619
Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression.
Li X and 9 others. Cell Death Dis, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression. Papers, record 41565619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41565619
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Ubiquitin Thiolesterase | Major topic |
| Adaptor Proteins, Signal Transducing | Major topic |
| Transcription Factors | Major topic |
| Feedback, Physiological | Major topic |
| Endopeptidases | Major topic |
| Phosphoproteins | Major topic |
| Humans | |
| Female | |
| Hippo Signaling Pathway | |
| YAP-Signaling Proteins | |
| Ubiquitination | |
| Signal Transduction | |
| Cell Line, Tumor | |
| Disease Progression | |
| Gene Expression Regulation, Neoplastic | |
| Animals | |
| Endosomal Sorting Complexes Required for Transport |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31,443,516 | Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge. | Cells | 2019 | https://conductscience.org/library/papers/31443516 | PubMed |
| 2 | 36,759,723 | The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36759723 | PubMed |
| 3 | 19,008,097 | What is triple-negative breast cancer? | Eur J Cancer | 2008 | https://conductscience.org/library/papers/19008097 | PubMed |
| 4 | 35,361,799 | USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy. | Nat Commun | 2022 | https://conductscience.org/library/papers/35361799 | PubMed |
| 5 | 32,863,938 | Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. | Theranostics | 2020 | https://conductscience.org/library/papers/32863938 | PubMed |
| 6 | 31,765,611 | GDF15 induced by compressive force contributes to osteoclast differentiation in human periodontal ligament cells. | Exp Cell Res | 2020 | https://conductscience.org/library/papers/31765611 | PubMed |
| 7 | 27,485,598 | Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium. | Carcinogenesis | 2016 | https://conductscience.org/library/papers/27485598 | PubMed |
| 8 | 34,813,758 | Deubiquitinases: From mechanisms to their inhibition by small molecules. | Mol Cell | 2022 | https://conductscience.org/library/papers/34813758 | PubMed |
| 9 | 32,206,112 | A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. | Theranostics | 2020 | https://conductscience.org/library/papers/32206112 | PubMed |
| 10 | 35,811,497 | USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII. | EMBO J | 2022 | https://conductscience.org/library/papers/35811497 | PubMed |
1 to 10 of 40
See all 40 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41,926,654 | Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41926654 |
Source PubMed
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| CCN1 | 3,491 | PubTator's text mining | https://conductscience.org/library/genes/3491 | NCBI Gene |
| CCN2 | 1,490 | PubTator's text mining | https://conductscience.org/library/genes/1490 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2,064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| FOSB | 2,354 | PubTator's text mining | https://conductscience.org/library/genes/2354 | NCBI Gene |
| FOSL1 | 8,061 | PubTator's text mining | https://conductscience.org/library/genes/8061 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| OTUB1 | 55,611 | PubTator's text mining | https://conductscience.org/library/genes/55611 | NCBI Gene |
| POMC | 5,443 | PubTator's text mining | https://conductscience.org/library/genes/5443 | NCBI Gene |
1 to 10 of 17
See all 17 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41565619
GET https://conductscience.org/api/papers/v1/41565619/references?page=2